Given the obvious complexity of NRF2 regulation both in normal cells and Onc-p53 cancer cells, a more detailed understanding of the mechanism of NRF2 regulation after PI treatment of NSCLC cells will require further study beyond the scope of this work. This evidence concerns the gene TP53 and cancer.